Mittal Vijay K, Bhullar Jasneet Singh, Jayant Kumar
Vijay K Mittal, Kumar Jayant, Department of Surgery, Providence Hospital and Medical Centers, Southfield, MI 48075, United States.
World J Gastroenterol. 2015 Nov 7;21(41):11854-61. doi: 10.3748/wjg.v21.i41.11854.
To make orthotopic colon cancer murine models a more clearly understood subject. The orthotopic tumor models have been found to be more relevant in replicating the human disease process as compared to heterotopic models, many techniques for making orthotopic colorectal murine models have been reported.
We evaluated the current literature for various reported orthotopic colon cancer models to understand their techniques, advantages and limitations. An extensive literature review was performed by searching the National Library of Medicine Database (PubMed) using MeSH terms animal model; colon cancer; orthotopic model; murine model. Twenty studies related to colon cancer orthotopic xenograft model were evaluated in detail and discussed here.
The detailed analysis of all relevant reports on orthotopic model showed tumor take rate between 42%-100%. While models using the enema technique and minimally invasive technique have reported development of tumor from mucosa with tumor take rate between 87%-100% with metastasis in 76%-90%.
Over the years, the increased understanding of the murine models of human colon cancer has resulted in the development of various models. Each reported model has some limitations. These latest models have opened up new doors for continuing cancer research for not only understanding the colon cancer pathogenesis but also aid in the development of newer chemotherapeutic drugs as they mimic the human disease closely.
使原位结肠癌小鼠模型成为更易于理解的研究对象。与异位模型相比,原位肿瘤模型在复制人类疾病过程方面更具相关性,目前已有许多构建原位结直肠癌小鼠模型的技术被报道。
我们评估了当前文献中各种已报道的原位结肠癌模型,以了解其技术、优点和局限性。通过使用医学主题词“动物模型;结肠癌;原位模型;小鼠模型”在国立医学图书馆数据库(PubMed)中进行检索,开展了广泛的文献综述。在此详细评估并讨论了20项与结肠癌原位异种移植模型相关的研究。
对所有原位模型相关报告的详细分析表明,肿瘤接种成功率在42% - 100%之间。虽然使用灌肠技术和微创技术的模型报告显示肿瘤从黏膜发展而来,肿瘤接种成功率在87% - 100%之间,转移率在76% - 90%之间。
多年来,对人类结肠癌小鼠模型的深入了解推动了各种模型的发展。每个已报道的模型都有一些局限性。这些最新模型为持续的癌症研究打开了新的大门,不仅有助于理解结肠癌的发病机制,还能因为它们与人类疾病高度相似而助力新型化疗药物的研发。